Malignant Multiple Neoplasms in Head and Neck Squamous Cell Carcinoma

被引:5
|
作者
Lopez Molla, Celia [1 ]
Estelles Ferriol, Enrique [1 ]
Carrasco Llatas, Marina [1 ]
Seijas Rosales, Teresa [1 ]
Morales Suarez-Varela, Maria [2 ]
Dalmau Galofre, Jose [1 ]
机构
[1] Hosp Univ Dr Peset, Serv Otorrinolaringol, Valencia, Spain
[2] Hosp Univ Dr Peset, Unidad Invest, Valencia, Spain
来源
ACTA OTORRINOLARINGOLOGICA ESPANOLA | 2008年 / 59卷 / 09期
关键词
Multiple malignant neoplasms; Head and neck squamous cell carcinoma; Metachronous; Second primary tumours;
D O I
10.1016/S0001-6519(08)75113-6
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction: The incidence of multiple malignant neoplasms in the upper aerodigestive tract is high and ranges from 7% to 20%. We make a retrospective study to evaluate the incidence of multiple malignant neoplasms in head and neck squamous cell carcinomas, their main characteristics and survival. Material and method: We studied 103 multiple malignant neoplasms from an oncological database of 1330 patients with head and neck squamous cell carcinomas. We use the SPSS v15 for analysis of the results. Results: The incidence of multiple malignant neoplasms in our series is 7.73 %. Tumours of the hypopharynx are the primary tumours most often associated with multiple malignant neoplasms (21.34 %), followed by tumours of the oropharynx (15.38 %). Lung tumours are the multiple malignant neoplasms most often associated (29.03 %). The 5- year global survival is 33 % from diagnosis of the second primary tumour, 78.02 % of which are metachronous with an average of 40 months between the diagnosis of the primary tumour and the presentation of the second tumour. Conclusions: Multiple malignant neoplasms are very frequent in the head and neck area which shows the importance of thorough regular check- ups of these patients as the presence of multiple malignant neoplasms considerably worsens the prognosis.
引用
收藏
页码:427 / 432
页数:6
相关论文
共 50 条
  • [31] Basaloid squamous cell carcinoma of the head and neck
    Paulino, AFG
    Singh, B
    Shah, JP
    Huvos, AG
    LARYNGOSCOPE, 2000, 110 (09): : 1479 - 1482
  • [32] Cutaneous squamous cell carcinoma of the head and neck
    Deutsch, Jochen
    Dippel, Edgar
    Delank, K. -Wolfgang
    LARYNGO-RHINO-OTOLOGIE, 2023, 102 (03) : 186 - 193
  • [33] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Jessica Moskovitz
    Jennifer Moy
    Robert L. Ferris
    Current Oncology Reports, 2018, 20
  • [34] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420
  • [35] Pharmacotherapy of head and neck squamous cell carcinoma
    Pan, Quintin
    Gorin, Michael A.
    Teknos, Theodoros N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (14) : 2291 - 2302
  • [36] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Schoppy, David W.
    Sunwoo, John B.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1033 - +
  • [37] Chemoprevention of squamous cell carcinoma of the head and neck
    Wrangle, John M.
    Khuri, Fadlo R.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (03) : 180 - 187
  • [38] MRI findings of extranodal malignant lymphoma and squamous cell carcinoma in the head and neck regions
    Tomoko Shiraishi
    Toru Chikui
    Daisuke Inadomi
    Marie Hashimoto
    Chika Horio
    Toyohiro Kagawa
    Kunihiro Miwa
    Kenji Yuasa
    Oral Radiology, 2016, 32 : 98 - 104
  • [39] The role of chromosomal aberrations in premalignant and malignant lesions in head and neck squamous cell carcinoma
    Abou-Elhamd, Kamal-Eldin Ahmed
    Habib, Tito Naeem
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2008, 265 (02) : 203 - 207
  • [40] MRI findings of extranodal malignant lymphoma and squamous cell carcinoma in the head and neck regions
    Shiraishi, Tomoko
    Chikui, Toru
    Inadomi, Daisuke
    Hashimoto, Marie
    Horio, Chika
    Kagawa, Toyohiro
    Miwa, Kunihiro
    Yuasa, Kenji
    ORAL RADIOLOGY, 2016, 32 (02) : 98 - 104